Narinder Pal Bhalla, Chief Medical Officer at Lexeo Therapeutics, Inc. (LXEO), sold 22,306 shares at $4.42 ($99K) on 2026-07-01, disclosed to the SEC on 2026-07-01.
Open-market sale of $99k LXEO by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.